Location: Home
  • search
  • go
  • Relate News
  • 2/12/2026China Indicts AstraZeneca and Former China Head Leon Wang Over Data an...
  • 2/12/2026UniXell Raises Over CNY 50M in Series A+ to Advance Stem Cell Therapy ...
  • 2/12/2026Lilly China's Mounjaro Approved for Type 2 Diabetes Monotherapy
  • 2/12/2026Lilly's Jaypirca Approved in China for Previously Treated CLL and SLL ...
  • 2/12/2026RemeGen Advances PD-1/VEGF BsAb RC148 Into Phase 3 Trials
  • 2/12/2026Ascletis Picks Oral Amylin Agonist ASC36 for Obesity Development, Plan...
  • 2/12/2026CDE Issues Draft Pharmaceutical Guidance for Rare Disease Chemical Dru...
  • 2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)
  • 2/12/2026China NMPA Approves Nine New Drugs in January 2026, Expanding Beyond O...
  • 2/11/2026NHSA Issues Trial Measures for Early Communication on Reference Drugs
  • 2/11/2026GSK's RSV Vaccine Arexvy Moves Forward in China
  • 2/11/2026China Eyes Approval for Russian Cancer Vaccine 'Enteromix'
  • 2/11/2026Shiling Pharma Targets 2028 for Nasal Spray Version of Wegovy Obesity ...
  • 2/11/2026Sanofi Backs GluBio's Molecular Glue Pill for Sickle Cell Disease
  • 2/11/2026Madrigal Expands MASH Pipeline with Six siRNA Programs from China's Ri...
  • 2/11/2026TenNor Therapeutics Files for Hong Kong IPO as Dual-Core Antibiotic Pi...
  • 2/11/2026Regend Raises CNY 350M Series C to Advance Cell-Based Organ Regenerati...
  • 2/11/2026Betta Pharma Wins China Approval for Pertuzumab Biosimilar in Breast C...
  • 2/11/2026Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...
  • 2/11/2026China Issues Revised Rules for National Essential Drug List Management
  • 2/10/20263D Medicines Advances Envafolimab Toward Full Market Approval in China
  • 2/10/2026Cascade Raises $72M to Advance MASH, Obesity and Diabetes Pipeline
  • 2/10/2026Hengrui and Kailera Advance Obesity Therapy After Encouraging Mid-Stag...
  • 2/10/2026Insilico and CMS Partner on AI-Driven CNS and Autoimmune Drug Programs
  • 2/10/2026Weekly China Regulatory Roundup: EGFR, TROP2 Approvals and Broad IND A...
  • 2/10/2026AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
  • 2/10/2026China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...
  • 2/10/2026China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
  • 2/9/2026Lilly Expands China Partnership With Innovent in New Global Oncology a...
  • 2/9/2026GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...
  • Page:1/817 Total number of articles:24501: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group